RHYTHM Biosciences Ltd
Research RHYTHM Biosciences Ltd (RHY) on Bullrun: market cap AUD 33.26M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRHY
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyAUD
- Market capAUD 33.26M
- Financial periodFY2024
- Net income-AUD 6.86M
- Free cash flow-AUD 6.22M
Valuation Snapshot
latest market cap is AUD 33.26M.
About RHYTHM Biosciences Ltd
Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia.
Frequently asked questions
What is RHYTHM Biosciences Ltd's market cap?
RHYTHM Biosciences Ltd's market capitalization is AUD 33.26M.
What does RHYTHM Biosciences Ltd do?
Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer;